Literature DB >> 25186257

High positive predictive value of Xpert in a low rifampicin resistance prevalence setting.

Anete Trajman1, Betina Durovni2, Valeria Saraceni3, Marcelo Cordeiro-Santos4, Frank Cobelens5, Susan van den Hof5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25186257     DOI： 10.1183/09031936.00115514

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  4 in total

1.  Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms.

Authors:  Adrienne E Shapiro; Jennifer M Ross; Mandy Yao; Ian Schiller; Mikashmi Kohli; Nandini Dendukuri; Karen R Steingart; David J Horne
Journal:  Cochrane Database Syst Rev       Date:  2021-03-23

2.  Rapid molecular test for tuberculosis: impact of its routine use at a referral hospital.

Authors:  Marilda Casela; Silvânia Maria Andrade Cerqueira; Thais de Oliveira Casela; Mariana Araújo Pereira; Samanta Queiroz Dos Santos; Franco Andres Del Pozo; Songeli Menezes Freire; Eliana Dias Matos
Journal:  J Bras Pneumol       Date:  2018-04       Impact factor: 2.624

3.  Impact of the GeneXpert® MTB/RIF rapid molecular test on tuberculosis detection: temporal trends and vulnerable territories.

Authors:  Thaís Zamboni Berra; Alexandre Tadashi Inomata Bruce; Yan Mathias Alves; Antônio Carlos Vieira Ramos; Clóvis Luciano Giacomet; Ricardo Alexandre Arcêncio
Journal:  Rev Lat Am Enfermagem       Date:  2021-07-19

4.  Challenges in detection and treatment of multidrug resistant tuberculosis patients in Vietnam.

Authors:  Thuy Thi Thanh Hoang; Nhung Viet Nguyen; Sy Ngoc Dinh; Hoa Binh Nguyen; Frank Cobelens; Guy Thwaites; Huong Thien Nguyen; Anh Thu Nguyen; Pamela Wright; Heiman F L Wertheim
Journal:  BMC Public Health       Date:  2015-09-29       Impact factor: 3.295
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.